Carregant...
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet available therapies only modestly improve clinical outcomes. Observational studies report independent associations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of ESRD,...
Guardat en:
| Publicat a: | J Am Soc Nephrol |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Nephrology
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4587706/ https://ncbi.nlm.nih.gov/pubmed/25967123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015020117 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|